Panretin (alitretinoin topical gel) — Medica

Initial criteria

• Patient is not receiving systemic therapy for Kaposi sarcoma
• Medication is prescribed by or in consultation with a dermatologist, oncologist, or infectious disease specialist

Approval duration

1 year